Meeting
2022 ASCO Annual Meeting
Impact of COVID-19 on individuals with paraganglioma/pheochromocytoma history and/or hereditary risk.
Authors
Samantha Greenberg
Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
Samantha Greenberg , Nicholas Yozamp , Amanda Anson , Sarah Brand , Luke Buchmann , Wendy Kohlmann , Sara Low , Bob Wong , Tobias Else , Anand Vaidya , Lauren Fishbein
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Hereditary Cancer Syndromes
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 10613)
DOI
10.1200/JCO.2022.40.16_suppl.10613
Abstract #
10613
Poster Bd #
487
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
A prospective ultrasonographic surveillance study on the incidence and recovery period of COVID-19 vaccination-related axillary lymphadenopathy following a booster shot.
First Author: Kumiko Kida
Poster
2022 ASCO Annual Meeting
Risk-stratified FIT for urgent colonoscopy in Lynch syndrome: A clinical service throughout the COVID-19 pandemic.
First Author: Anne G Lincoln
Poster
2021 ASCO Annual Meeting
Disparities in surveillance imaging after breast conserving surgery for primary DCIS.
First Author: Danalyn Byng
Poster
2020 ASCO Virtual Scientific Program
Cost-utility analysis of surveillance strategies for soft tissue sarcoma recurrence.
First Author: Bonny Chau